Janney Montgomery Scott LLC grew its position in shares of Exelixis, Inc. (NASDAQ:EXEL – Get Rating) by 13.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 57,608 shares of the biotechnology company’s stock after acquiring an additional 6,858 shares during […]
Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
Athira Pharma (NASDAQ:ATHA – Get Rating) and Exelixis (NASDAQ:EXEL – Get Rating) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership. Institutional and Insider Ownership 58.7% of Athira Pharma shares are held […]
Athira Pharma (NASDAQ:ATHA – Get Rating) and Exelixis (NASDAQ:EXEL – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, profitability, valuation, dividends, institutional ownership and earnings. Volatility & Risk Athira Pharma has a beta of 2.82, suggesting […]